NCT03604198 2026-02-19
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
Corcept Therapeutics
University of Pittsburgh
Medicine Invention Design, Inc
Charles Drew University of Medicine and Science
University of Toronto